The research team enrolled children between the ages of 1 and 5 years from eight U.S. sites between October 2014 and February 2016. They matched children with a positive C. diff specimen to a control group. The C. diff patients had not been admitted to a healthcare facility in the 12 weeks prior, nor did they have a history of C. diff infection. There were 68 pairs of patients in the study.
The following factors were more common among C. diff patients compared to controls:
● A comorbidity (33.3 percent among C. diff patients versus 12.1 percent among controls)
● Recent antibiotic use (54.4 percent versus 19.4 percent)
● Recent higher-risk outpatient exposures (34.9 percent versus 17.7 percent)
● Recent exposure to a household member with diarrhea (41.3 percent versus 21.5 percent)
Researchers also found antibiotic exposure in the prior 12 weeks was significantly associated with community-associated C. diff infection.
More articles on healthcare quality:
833 deaths linked to Congo’s Ebola outbreak: 4 updates
10 health systems hiring medical informatics leaders
Risk of death increases with each day of staph infection, study finds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
